A new method that prevents the loss of silencing activity of double-strand RNA in humans
Since the discovery that short double-strand RNA molecules (siRNAs) can trigger sequence-specific degradation of target RNA in cells, great efforts are going on throughout the world to use siRNAs in human therapy.
The group of Dr. Dr. Albrecht Piiper at the Saarland University discovered a way to defend double-stranded and partial double-stranded molecules of RNA – particularly siRNAs – from degradation by RNAse in mammalian body fluid including humans.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/9386376
Contact
Dipl.-Kfm. Axel Koch MBA, Dr. Dirk Schwingel
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Magnetic tornado is stirring up the haze at Jupiter’s poles
Unusual magnetically driven vortices may be generating Earth-size concentrations of hydrocarbon haze. While Jupiter’s Great Red Spot has been a constant feature of the planet for centuries, University of California,…
Cause of common cancer immunotherapy side effect s
New insights into how checkpoint inhibitors affect the immune system could improve cancer treatment. A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation…
New tool makes quick health, environmental monitoring possible
University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, environmental monitoring groups, or even you, the ability to quickly detect harmful and health-relevant substances…